Stanley J. Cryz

7.0k total citations
133 papers, 5.3k citations indexed

About

Stanley J. Cryz is a scholar working on Endocrinology, Immunology and Epidemiology. According to data from OpenAlex, Stanley J. Cryz has authored 133 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, 44 papers in Immunology and 37 papers in Epidemiology. Recurrent topics in Stanley J. Cryz's work include Vibrio bacteria research studies (33 papers), Escherichia coli research studies (25 papers) and Antibiotic Resistance in Bacteria (21 papers). Stanley J. Cryz is often cited by papers focused on Vibrio bacteria research studies (33 papers), Escherichia coli research studies (25 papers) and Antibiotic Resistance in Bacteria (21 papers). Stanley J. Cryz collaborates with scholars based in Switzerland, United States and Austria. Stanley J. Cryz's co-authors include E Fürer, R. Germanier, Myron M. Levine, B H Iglewski, Jerald Sadoff, Aloïs B. Lang, Dennis E. Ohman, James B. Kaper, Alan S. Cross and J U Que and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Stanley J. Cryz

131 papers receiving 5.0k citations

Peers

Stanley J. Cryz
James Brunton Canada
M. John Albert Bangladesh
Sören Schubert Germany
Sebastián Albertí Spain
S L Moseley United States
Renato Morona Australia
Elizabeth L. Hartland Australia
J Heesemann Germany
Derek Pickard United Kingdom
Sandra Reuter Germany
James Brunton Canada
Stanley J. Cryz
Citations per year, relative to Stanley J. Cryz Stanley J. Cryz (= 1×) peers James Brunton

Countries citing papers authored by Stanley J. Cryz

Since Specialization
Citations

This map shows the geographic impact of Stanley J. Cryz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley J. Cryz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley J. Cryz more than expected).

Fields of papers citing papers by Stanley J. Cryz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley J. Cryz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley J. Cryz. The network helps show where Stanley J. Cryz may publish in the future.

Co-authorship network of co-authors of Stanley J. Cryz

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley J. Cryz. A scholar is included among the top collaborators of Stanley J. Cryz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley J. Cryz. Stanley J. Cryz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cryz, Stanley J., et al.. (2015). A Polyvalent Pseudomonas aeruginosa O-Polysaccharide-Toxin A Conjugate Vaccine. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 39. 249–255. 3 indexed citations
2.
3.
Dilts, Deborah A., Erik Ekwall, Carl Granert, et al.. (2000). Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. Vaccine. 18(15). 1473–1484. 32 indexed citations
4.
Kollaritsch, Herwig, Stanley J. Cryz, Aloïs B. Lang, et al.. (2000). Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization. Vaccine. 18(26). 3031–3039. 17 indexed citations
5.
Rubinstein, Arye, Massimo Pettoello‐Mantovani, Jack Lenz, et al.. (1999). Immunologic Responses of HIV-1–Infected Study Subjects to Immunization With a Mixture of Peptide Protein Derivative–V3 Loop Peptide Conjugates. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(5). 467–467. 3 indexed citations
6.
Cross, Alan S., Steven M. Opal, Apurba K. Bhattacharjee, et al.. (1999). Immunotherapy of sepsis: flawed concept or faulty implementation?. Vaccine. 17. S13–S21. 20 indexed citations
7.
8.
Reibel, Susanne, Aloïs B. Lang, E Gerike, et al.. (1998). Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. Vaccine. 16(2-3). 298–304. 39 indexed citations
9.
Althaus, Beat, et al.. (1997). Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients. Vaccine. 15(15). 1675–1679. 86 indexed citations
10.
Hougen, Hans Petter, et al.. (1995). Vaccination Promotes TH1-Like Inflammation and Survival in Chronic Pseudomonas Aeruginosa Pneumonia in Rats. American Journal of Respiratory and Critical Care Medicine. 152(4). 1337–1346. 37 indexed citations
11.
Lang, Aloïs B., Urs B. Schaad, A Rüdeberg, et al.. (1995). Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. The Journal of Pediatrics. 127(5). 711–717. 41 indexed citations
12.
Tacket, Carol O., Genevieve A. Losonsky, James P. Nataro, et al.. (1995). Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89(1). 75–77. 24 indexed citations
13.
Tacket, Carol O., G Losonsky, James P. Nataro, et al.. (1993). Safety and Immunogenicity of Live Oral Cholera Vaccine Candidate CVD 110, a  ctxA ctxAzot zotace Derivative of El Tor Ogawa Vibrio cholerae. The Journal of Infectious Diseases. 168(6). 1536–1540. 79 indexed citations
14.
Lang, Aloïs B., et al.. (1993). Feasibility of prophylaxis and therapy against Gram-negative infections by human monoclonal antibodies. FEMS Immunology & Medical Microbiology. 7(1). 9–13.
15.
Cryz, Stanley J.. (1992). Live attenuated vaccines for human use. Current Opinion in Biotechnology. 3(3). 298–302. 2 indexed citations
16.
Suharyono, Suharyono, C. H. Simanjuntak, Narain H. Punjabi, et al.. (1992). Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. The Lancet. 340(8821). 689–694. 122 indexed citations
17.
Schaad, U. B., J Wedgwood, Aloïs B. Lang, et al.. (1991). Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. The Lancet. 338(8777). 1236–1237. 68 indexed citations
18.
Bruderer, Urs, E Fürer, Stanley J. Cryz, & Aloïs B. Lang. (1990). Qualitative analysis of antibody binding. Journal of Immunological Methods. 133(2). 263–268. 10 indexed citations
19.
Levine, MyronM., D A Herrington, Ben D. Tall, et al.. (1988). SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR. The Lancet. 332(8609). 467–470. 260 indexed citations
20.
Cryz, Stanley J., et al.. (1988). Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine. European Journal of Immunology. 18(12). 2073–2075. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Brunton Breakdown of academic impact, for papers by M. John Albert Breakdown of academic impact, for papers by Sören Schubert Breakdown of academic impact, for papers by Sebastián Albertí Breakdown of academic impact, for papers by S L Moseley Breakdown of academic impact, for papers by Renato Morona Breakdown of academic impact, for papers by Elizabeth L. Hartland Breakdown of academic impact, for papers by J Heesemann Breakdown of academic impact, for papers by Derek Pickard Breakdown of academic impact, for papers by Sandra Reuter
Rankless by CCL
2026